Pierre Fabre’s laboratory was founded 50 years ago, when Pierre Fabre developed the Cyclo 3 drug. Since then, a significant part of the turnover from their pharmaceutical activities has been spent on R&D for innovative treatments. They often work in partnership with public or private research laboratories to develop the drugs of tomorrow, mainly in the field of onco-hematology, neuropsychiatry and dermatology. They design and develop consumer and patient inspired innovative solutions that contribute to people’s well-being, from health to beauty.
Product distributed by Pnl: Tanganil, Brexin